Home › Funds › Integral Health Asset Management, LLC › RYTM

Integral Health Asset Management, LLC position in RYTM

RHYTHM PHARMACEUTICALS INC · Health Care

Integral Health Asset Management, LLC reported holding 250,000 shares of RYTM (RHYTHM PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$11.9M, representing 0.77% of its reported portfolio and ranking #43 among its reported holdings. Integral Health Asset Management, LLC has disclosed RYTM holdings in 7 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)250.00K sh
Reported value held$11.90M
Portfolio Weight0.77%
First reportedQ4 2024
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Integral Health Asset Management, LLC's RYTM position evolved

Integral Health Asset Management, LLC first disclosed a stake in RYTM in Q4 2024 at 150,000 shares (US$8.4M). The position peaked in Q2 2026 at 550,000 shares, worth US$61.1M. Across 7 filings, Integral Health Asset Management, LLC increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 250,000 shares valued at US$11.9M — a reduction of -300,000 shares quarter over quarter.. Notable position changes include a 83% increase in Q3 2025 (shares rose 6% over the following quarter), a 116% increase in Q4 2025 (shares fell 19% over the following quarter), a 55% trim in Q3 2026 (shares rose 21% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 150.00K $8.40M New
Q2 2025 120.00K $7.58M New
Q3 2025 220.00K $22.22M Add
Q4 2025 475.00K $50.84M Add
Q1 2026 600.00K $52.18M Add
Q2 2026 550.00K $61.07M Reduce
Q3 2026 250.00K $11.90M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RYTM and 13F data

RYTM (RHYTHM PHARMACEUTICALS INC) is a Health Care company. 40 other funds we track also report a position in RYTM — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$740.2M), BAKER BROS. ADVISORS LP (US$622.3M), PERCEPTIVE ADVISORS LLC (US$287.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RYTM

All RYTM fund holders →

FAQ

How long has Integral Health Asset Management, LLC held RYTM?

Integral Health Asset Management, LLC has disclosed RYTM holdings in 7 of the last 8 reported quarters, going back to Q4 2024.

What is Integral Health Asset Management, LLC's current position in RYTM?

As of Q3 2026, Integral Health Asset Management, LLC holds 250.00K shares of RYTM (RHYTHM PHARMACEUTICALS INC), valued at $11.90M, representing 0.77% of its reported portfolio and ranking #43.

Has Integral Health Asset Management, LLC been buying or selling RYTM?

In the latest 13F filing (Q3 2026), Integral Health Asset Management, LLC reduced its position in RYTM. The position peaked in Q2 2026 at 550.00K shares.

Which other funds hold RYTM?

Other major institutional holders of RYTM include RA CAPITAL MANAGEMENT, L.P., BAKER BROS. ADVISORS LP, PERCEPTIVE ADVISORS LLC, among 40 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.